These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 19714451)

  • 21. Curcumin synergistically potentiates the growth inhibitory and pro-apoptotic effects of celecoxib in pancreatic adenocarcinoma cells.
    Lev-Ari S; Zinger H; Kazanov D; Yona D; Ben-Yosef R; Starr A; Figer A; Arber N
    Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S276-80. PubMed ID: 16507392
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of spirostanol glycosides and furostanol glycosides from anemarrhenae rhizoma as dual targeted inhibitors of 5-lipoxygenase and Cyclooxygenase-2 by employing a combination of affinity ultrafiltration and HPLC/MS.
    Xie L; Lee DY; Shang Y; Cao X; Wang S; Liao J; Zhang T; Dai R
    Phytomedicine; 2020 Oct; 77():153284. PubMed ID: 32707371
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Curcumin-attenuated trinitrobenzene sulphonic acid induces chronic colitis by inhibiting expression of cyclooxygenase-2.
    Jiang H; Deng CS; Zhang M; Xia J
    World J Gastroenterol; 2006 Jun; 12(24):3848-53. PubMed ID: 16804969
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells.
    Basak SK; Zinabadi A; Wu AW; Venkatesan N; Duarte VM; Kang JJ; Dalgard CL; Srivastava M; Sarkar FH; Wang MB; Srivatsan ES
    Oncotarget; 2015 Jul; 6(21):18504-17. PubMed ID: 26098778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis.
    Li L; Aggarwal BB; Shishodia S; Abbruzzese J; Kurzrock R
    Cancer; 2004 Nov; 101(10):2351-62. PubMed ID: 15476283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation.
    Mohanty C; Sahoo SK
    Biomaterials; 2010 Sep; 31(25):6597-611. PubMed ID: 20553984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Curcumin analog GO-Y030 is a novel inhibitor of IKKβ that suppresses NF-κB signaling and induces apoptosis.
    Sato A; Kudo C; Yamakoshi H; Uehara Y; Ohori H; Ishioka C; Iwabuchi Y; Shibata H
    Cancer Sci; 2011 May; 102(5):1045-51. PubMed ID: 21272158
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potential interaction of natural dietary bioactive compounds with COX-2.
    Maldonado-Rojas W; Olivero-Verbel J
    J Mol Graph Model; 2011 Sep; 30():157-66. PubMed ID: 21803623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A validated LC-MS/MS method for quantitative analysis of curcumin in mouse plasma and brain tissue and its application in pharmacokinetic and brain distribution studies.
    Ramalingam P; Ko YT
    J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Oct; 969():101-8. PubMed ID: 25168793
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chloro and bromo-pyrazole curcumin Knoevenagel condensates augmented anticancer activity against human cervical cancer cells: design, synthesis,
    Chaudhary M; Kumar N; Baldi A; Chandra R; Arockia Babu M; Madan J
    J Biomol Struct Dyn; 2020 Jan; 38(1):200-218. PubMed ID: 30784365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anticancer agents and COX-2 inhibitors.
    Şenkardeş S; Han Mİ; Kulabaş N; Abbak M; Çevik Ö; Küçükgüzel İ; Küçükgüzel ŞG
    Mol Divers; 2020 Aug; 24(3):673-689. PubMed ID: 31302853
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validated LC/MS/MS assay for curcumin and tetrahydrocurcumin in rat plasma and application to pharmacokinetic study of phospholipid complex of curcumin.
    Liu A; Lou H; Zhao L; Fan P
    J Pharm Biomed Anal; 2006 Feb; 40(3):720-7. PubMed ID: 16316738
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Curcumin inhibits phorbol ester-induced up-regulation of cyclooxygenase-2 and matrix metalloproteinase-9 by blocking ERK1/2 phosphorylation and NF-kappaB transcriptional activity in MCF10A human breast epithelial cells.
    Lee KW; Kim JH; Lee HJ; Surh YJ
    Antioxid Redox Signal; 2005; 7(11-12):1612-20. PubMed ID: 16356124
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In-silico and in-vitro anti-cancer potential of a curcumin analogue (1E, 6E)-1, 7-di (1H-indol-3-yl) hepta-1, 6-diene-3, 5-dione.
    Sufi SA; Adigopula LN; Syed SB; Mukherjee V; Coumar MS; Rao HS; Rajagopalan R
    Biomed Pharmacother; 2017 Jan; 85():389-398. PubMed ID: 27889234
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Novel Triple Stage Ion Trap MS method validated for curcumin pharmacokinetics application: A comparison summary of the latest validated curcumin LC/MS methods.
    Li W; Yang H; Buckley B; Wang L; Kong AN
    J Pharm Biomed Anal; 2018 Jul; 156():116-124. PubMed ID: 29702389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and pharmacokinetic evaluation of a curcumin co-solvent formulation.
    John MK; Xie H; Bell EC; Liang D
    Anticancer Res; 2013 Oct; 33(10):4285-91. PubMed ID: 24122994
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design and Synthesis of Curcumin-Like Diarylpentanoid Analogues as Potential Anticancer Agents.
    Qudjani E; Iman M; Davood A; Ramandi MF; Shafiee A
    Recent Pat Anticancer Drug Discov; 2016; 11(3):342-51. PubMed ID: 27094172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences.
    Garcea G; Berry DP; Jones DJ; Singh R; Dennison AR; Farmer PB; Sharma RA; Steward WP; Gescher AJ
    Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):120-5. PubMed ID: 15668484
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.
    Lu X; Zhang H; Li X; Chen G; Li QS; Luo Y; Ruan BF; Chen XW; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(22):6827-32. PubMed ID: 22000948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts.
    Zhu S; Moore TW; Morii N; Howard RB; Culver D; Arrendale RF; Reddy P; Evers TJ; Zhang H; Sica G; Chen ZG; Sun A; Fu H; Khuri FR; Shin DM; Snyder JP; Shoji M
    Curr Cancer Drug Targets; 2014; 14(4):380-93. PubMed ID: 24628271
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.